Skip to Main Content

Paper Details

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
Eur Urol Oncol
0
2023
Germline Variants, PCa, PGVs, Patients, Prostate Cancer, Prostate cancer, cancer, cancer predisposition genes, germline, inherited variant, multigene, patient, patients, prostate cancer
Author NameAffiliation
Ryan D HernandezUniversity of California San Francisco
Kathryn E HatchellInvitae Corporation
Robert L NussbaumInvitae Corporation, University of California San Francisco
Sarah M NielsenInvitae Corporation
Edward D EsplinInvitae Corporation
Edward D EsplinInvitae Corporation
  • 1 - 6

Datasets

Release 1.2